Ariad Pharmaceuticals is Ready to Continue to Fill the Gap

This chart represents my view of the near term increase in price per share of Ariad Pharmaceuticals. I am long shares (small position) and am planning on adding significantly in the immediate future. Ariad has been through a couple major events recently and are in the midst of recovering (part of) a large gap-down that initiated in October 2013.

I believe short interest has played a role in the recent share price decline and some of the short interest is "hanging around too long" and will be forced to cover at higher prices in the form of a "squeeze".

I am expecting the price per share to be at or above $10.00 by the end of February 2014.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.